Duan, W., & Liu, Y. (2018). Targeted and synergistic therapy for hepatocellular carcinoma: Monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Des Devel Ther.
Chicago Style aipamenaDuan, Wendu, and Yan Liu. "Targeted and Synergistic Therapy for Hepatocellular Carcinoma: Monosaccharide Modified Lipid Nanoparticles for the Co-delivery of Doxorubicin and Sorafenib." Drug Des Devel Ther 2018.
MLA aipamenaDuan, Wendu, and Yan Liu. "Targeted and Synergistic Therapy for Hepatocellular Carcinoma: Monosaccharide Modified Lipid Nanoparticles for the Co-delivery of Doxorubicin and Sorafenib." Drug Des Devel Ther 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.